Literature DB >> 3162455

Phorbol esters and diacylglycerols amplify bradykinin-stimulated prostaglandin synthesis in Swiss 3T3 fibroblasts. Possible independence from protein kinase C.

R M Burch1, A L Ma, J Axelrod.   

Abstract

When Swiss 3T3 fibroblasts were incubated with bradykinin, prostaglandin E2 (PGE2) synthesis was stimulated. Phorbol esters or the diacylglycerol analog 1-oleoyl-2-acetylglycerol (OAG), by themselves, did not acutely stimulate PGE2 synthesis. However, when cells were preincubated with phorbol esters or OAG, bradykinin-stimulated PGE2 synthesis was potentiated markedly. When phorbol esters and OAG were added together, bradykinin-stimulated PGE2 synthesis was potentiated in an additive manner. When cells were preincubated for 48 h with phorbol esters, then bradykinin added, amplification of bradykinin-stimulated PGE2 synthesis by phorbol ester or OAG was still apparent, even though prolonged pretreatment with phorbol esters abolished protein kinase C (Ca2+/phospholipid-dependent enzyme) activity in cell-free preparations. Further, the protein kinase C antagonist, H-7, only slightly inhibited phorbol ester or OAG amplification of bradykinin-stimulated PGE2 synthesis. The possibility is raised that diacylglycerol, formed in response to many receptors, may serve as a transducer of receptor-receptor interactions. Since desensitization or inhibition of protein kinase C only partially reduced the amplification of bradykinin-stimulated PGE2 synthesis by phorbol esters or OAG, the possibility is raised that diacylglycerol mimetics may have actions in addition to activation of protein kinase C.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3162455

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Interleukin 1 amplifies receptor-mediated activation of phospholipase A2 in 3T3 fibroblasts.

Authors:  R M Burch; J R Connor; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1988-09       Impact factor: 11.205

2.  Interleukin-1 generates transmembrane signals from phospholipids through novel pathways in cultured rat mesangial cells.

Authors:  M Kester; M S Simonson; P Mené; J R Sedor
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

3.  Positive cooperativity between the thrombin and bradykinin B2 receptors enhances arachidonic acid release.

Authors:  Claudie Hecquet; Dauren Biyashev; Fulong Tan; Ervin G Erdös
Journal:  Am J Physiol Heart Circ Physiol       Date:  2005-09-23       Impact factor: 4.733

4.  Modulation of receptor-mediated signal transduction by diacylglycerol mimetics in astrocytes.

Authors:  R M Burch; D A Kniss
Journal:  Cell Mol Neurobiol       Date:  1988-06       Impact factor: 5.046

5.  Stimulation of arachidonic acid release and inhibition of mitogenesis by cloned genes for muscarinic receptor subtypes stably expressed in A9 L cells.

Authors:  B R Conklin; M R Brann; N J Buckley; A L Ma; T I Bonner; J Axelrod
Journal:  Proc Natl Acad Sci U S A       Date:  1988-11       Impact factor: 11.205

6.  Modulation of arachidonic acid metabolism by Rous sarcoma virus.

Authors:  K Barker; A Aderem; H Hanafusa
Journal:  J Virol       Date:  1989-07       Impact factor: 5.103

7.  Diacylglycerol accumulation and microvascular abnormalities induced by elevated glucose levels.

Authors:  B A Wolf; J R Williamson; R A Easom; K Chang; W R Sherman; J Turk
Journal:  J Clin Invest       Date:  1991-01       Impact factor: 14.808

8.  Angiogenin stimulates endothelial cell prostacyclin secretion by activation of phospholipase A2.

Authors:  R Bicknell; B L Vallee
Journal:  Proc Natl Acad Sci U S A       Date:  1989-03       Impact factor: 11.205

9.  Synergistic activation of type III protein kinase C by cis-fatty acid and diacylglycerol.

Authors:  S G Chen; K Murakami
Journal:  Biochem J       Date:  1992-02-15       Impact factor: 3.857

10.  Interleukin 1 alpha causes rapid activation of cytosolic phospholipase A2 by phosphorylation in rat mesangial cells.

Authors:  J Gronich; M Konieczkowski; M H Gelb; R A Nemenoff; J R Sedor
Journal:  J Clin Invest       Date:  1994-03       Impact factor: 14.808

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.